Latest / Wilmington News Today | 2 Min News | The Daily News Now!
Lilly Under Fire Over China Trials | Wilmington News
The House committee is probing Eli Lilly’s clinical trials in China, demanding records from military-linked hospitals and Xinjiang sites amid growing congressional concern over U.S. drug companies’ ties with China. With over 220 studies since 2003 and a $6 billion investment, Lilly’s expanding presence raises alarms about national security, IP theft, and human rights. While no illegal activity has been proven, lawmakers warn China’s biotech push could exploit American research. Lilly has until July 17th to respond. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.